Since then, US stocks have virtually ignored the economic risks sowed by President Donald Trump’s trade war to march back to ...

Despite recent economic headwinds, a resilient corporate earnings backdrop and better-than-feared data offer some optimism.

A tame CPI release on Tuesday could catalyze a shift in market leadership toward small-caps and lower-quality stocks. That’s ...

What ultimately happens is anybody's guess, but long-time market watcher and Morgan Stanley Chief Strategist Mike Wilson ...

Morgan Stanley's Mike Wilson thinks sectors like housing, commodities, and consumer goods could contain the biggest buying ...

Morgan Stanley predicts a bullish market with recovery in earnings revisions, citing AI capex cycles, dollar weakness, & Fed ...

Mike Wilson, Morgan Stanley chief U.S. equity strategist, joins 'Squawk Box' to discuss the latest market trends, state of ...

Investing.com -- Morgan Stanley strategist Mike Wilson reiterated his bullish stance on U.S. equities in a note Monday, ...

The new highs keep coming. Futures early Monday showed the S&P 500 on course for its 15th record of 2025. Tariff deals at levels that eight months ago would have been considered economically damaging ...

Earnings are in the midst of a "rolling recovery" that'll boost the S&P 500. AI, fiscal policy, and rate cuts will help the ...

The US economy is in "a new bull market," according to Mike Wilson, Morgan Stanley's chief US equity strategist.

Rhythm Pharmaceuticals, Inc. (NASDAQ: RYTM) is one of the Best All-Time High Stocks to Buy According to Analysts. On July 28, ...